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Electrospun Silk Fibroin Scaffolds with Macropores
for Bone Regeneration: An In Vitro and In Vivo Study
Sook Young Park, M.S.,1,* Chang Seok Ki, Ph.D.,2,3,* Young Hwan Park, Ph.D.,2,3,*
Hong Moon Jung, M.S.,4 Kyung Mi Woo, M.D., Ph.D.,4 and Hyun Jeong Kim, M.D., Ph.D.1,*
We developed three-dimensional electrospun silk fibroin (ESF) scaffolds with controllable pore size. The purpose
of this study was to evaluate ESF scaffolds with pores (P-ESF) for bone regeneration via in vitro and in vivo
studies, with a comparison to a commercially available porous three-dimensional polylactic acid (PLA) scaffold.
P-ESF supported significantly higher proliferation and alkaline phosphatase activity of osteoblasts than PLA
in vitro ( p< 0.05). Moreover, higher expression levels of activated adhesion-related proteins, including focal
adhesion kinase, were observed in the P-ESF than in PLA, as confirmed by western blot analyses. Micro-
computed tomography revealed that 78.30% of the original bone volume was attained in the P-ESF implantation
group at 7 weeks after critical bone defect formation in rat calvaria. Comparatively, the PLA implantation group
showed only 49.31%. Histological evaluation also showed new bone tissue formation upon P-ESF implantation.
Taken together, the P-ESF scaffold may be a good bone substitute for bone regeneration.
Introduction
Bone remodeling is a dynamic process not only inpathological but also under normal conditions in the
body. Bone has a three-dimensional (3D), mineralized struc-
ture. Bone is continuously degraded and regenerated by in-
teraction between osteoclasts and osteoblasts.1–3 However,
adequate bone regeneration may be limited when the defect
is beyond the natural regeneration capacity.
Clinically, implantations of autograft, allograft, xenograft,
metallic implants, and artificial synthetic materials are used
for large defects. Until now, the best way for repairing a
critical bone defect was autograft. However, the autograft
has several limitations, including the necessity of another
operation besides the defect area and functional impairment
of the donor site. Grafting materials from others can also
cause risk of serious systemic infection from donors, immune
rejection, chronic immune responses, and toxicity. Therefore,
a wide variety of novel materials and methods are still being
developed and suggested based on tissue engineering tech-
niques for bone regeneration.4–6
Silk is an organic fiber produced by silk worms, and is one
of the strongest and toughest materials known. Structurally,
native silkworm silk protein from Bombyx mori consists of a
core structural fibroin protein surrounded by sericin, a glue-
like protein. Fibroin is well known for being biocompatible
and cytocompatible, and thus it is a promising biomaterial
for bone regeneration.7–11
Recently, electrospinning using a high electric field has
become popular for making biomaterials. This technique can
provide many kinds of scaffolds with a large surface area
and natural extracellular matrix (ECM)-like structure, which
is vital for cellular attachment and proliferation.12,13 The
electrospun 3D scaffolds (electrospun silk fibroin [ESF]) ex-
hibit a high efficiency for cell attachment in early stages
of cell culture, and its highly porous structure is beneficial
to nutrient or gas exchange for cells.14–16 Usually, electro-
spun scaffolds have been limited to a two-dimensional (2D)
sheet because of the conventional collecting method using
a metal plate or mandrel. Recently, we developed a pore
size-controllable 3D ESF (P-ESF) via a salt-leaching method
where various sized NaCl particles act to control pores in the
middle of a silk fibroin mass.17,18
In this study, we compared pore size-matched P-ESF
with a commercially available sponge-type 3D polylactic
acid (PLA) scaffold using an osteoblast cell line, MC3T3-E1,
in vitro in terms of cellular viability, proliferation, and os-
teoblast differentiation. Moreover, we applied the P-ESF
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scaffold to critical bone defects of rat calvaria. We also
compared bone formation between P-ESF and PLA scaffolds
using microcomputed tomography (mCT) and hematoxylin
and eosin (H&E) staining at 7 weeks after bone defect sur-
gery. Nonporous ESF (N-ESF) scaffold, normal calvaria, and
defected calvaria were also evaluated to compare the bone
regeneration of P-ESF within in vivo experiments.
Materials and Methods
Materials
Bombyx mori cocoons were boiled in aqueous sodium car-
bonate solution (0.2%, w=v) with sodium oleate (0.3%, w=v)
for 1 h and washed with distilled water to remove sericin.
Then the degummed cocoons were dissolved in a ternary
solvent of CaCl2=H2O=EtOH (mole ratio: 1=8=2) at 858C for
3 min, and the SF aqueous solution was dialyzed against
distilled water for 3 days and lyophilized. The other solvents
and chemicals were used without further purification.
Scaffold preparations
Electrospinning and fabrication. At first, SF fiber disper-
sion was obtained by electrospinning. The 13% (w=v) dope
solution was prepared by dissolving the lyophilized SF in
formic acid. The resulting solution was poured into a syringe
with a 22-G needle connected to a DC high voltage power
supply (Chungpa EMT, Seoul, Korea). The entire electro-
spinning apparatus and details were designed from previous
reports.17,18 A methanol coagulation bath, which collected
and recrystallized the electrospun SF fibers, was located 20 cm
below the needle. The dope solution feed rate was accurately
controlled to match the spin speed and the applied voltage
was 13 kV.
The collected SF fiber dispersion was moved into a glass
vessel. Then methanol (dispersion medium) was exchanged
with 1,4-dioxane and sodium chloride particles (porogen)
with varying diameters, ranging from 50 to 100, 100 to 200,
and 300 to 500 mm. The amount of added salt was 0.15 g=mL
irrespective of particle size. Subsequently, the mixture was
gently stirred to mix the particles with the SF fibers and then
molded in a glass tube (I.D.: 6 mm). The molded SF fiber
assembly was lyophilized and subsequently exposed to
glutaraldehyde vapor in a sealed desiccator for 1 day. Then
the molded SF fiber assembly was detoxified with 0.1 M
glycine buffer (pH 9.2) and subsequently washed with
phosphate-buffered saline several times.19 The final shape of
the SFS was a disk form (6 mm diameter and 1.5 mm thick).
The porous but not fibrous poly(lactic acid) (PLA) scaffolds
of same pore dimension (BD 3-D Scaffold OPLA, cat. no.
REF 354614; BD Falcon, Sparks, MD) were used as a control
group. Each sample designation is listed in Table 1.
Morphological structure analysis. The morphological
structure of the scaffold was observed via scanning electron
microscopy. The diameter of the SF fiber was determined
using image software (Adobe Photoshop, San Jose, CA) and
the pore size was determined by calculating the equivalent
circular diameter after measuring the pore cross-sectional
area. Equivalent circular diameter denotes the diameter of a
circle that has the same area as the pore cross-section.
Porosity and water uptake measurement. The porosity
measurement of ESF was calculated by a previously reported
method.20 The bulk and fiber densities (rB and rF) were









where m1 and m2 are the masses of ESFs in air and n-hexane
after a brief vacuum, respectively, D is diameter, and t is
thickness. rH is the density of n-hexane at 258C. From rB and
rF, the porosity could be calculated as shown in Equation (3).




On the other hand, water uptake was determined by
Equation (4) after soaking the ESF in phosphate-buffered
saline for 1 h.
Water uptake (%)¼ mwmd
md
· 100 (4)
where md and mw are the masses in dry and wet states,
respectively.
Cell culture and in vitro test
MC3T3-E1 clone 4 cells were cultured in a-minimum es-
sential medium supplemented with 10% (v=v) fetal bovine
serum and 1% (v=v) antibiotic=antimycotic solution at 378C
in a humidified, 5% CO2 atmosphere. After harvest, cells
were seeded directly on each sterilized scaffold (2.5105
cells=cm2). Some of the samples were observed by scanning
electron microscope (SEM, JEM-T300; Jeol, Tokyo, Japan)
after each culture period.
The remaining samples were tested via DNA content, MTT,
and alkaline phosphatase (ALP) assays to measure the cell
proliferation and mineralization (n¼ 5 per group). DNA of
cells on scaffolds was isolated following the kit protocol
(Qiagen, Valencia, CA) and the concentration was measured
Table 1. Various Pore-Sized Fibrous Silk Fibroin
Scaffolds Used in This Study
Scaffolds
N-ESF Silk fibroin scaffold without pores
(NaCl particles were not added)
S-ESF Silk fibroin scaffold with small pores
(NaCl particle size: 50–100mm)
M-ESF (P-ESF) Silk fibroin scaffold with medium pores
(NaCl particle size: 100–200mm)
L-ESF Silk fibroin scaffold with large pores
(NaCl particle size: 300–500mm)
PLA Commercial PLLA scaffold purchased
from BD Falcon (pore size: 100–200 mm)
N-ESF, nonporous electrospun silk fibroin; S-ESF, small ESF;
M-ESF, medium ESF; P-ESF, ESF with pores; L-ESF, large ESF; PLA,
polylactic acid.
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using a spectrometer (ND-1000; NanoDrop, Wilmington, DE).
For MTT assay, samples were incubated at 378C in 5% CO2 for
4 h in serum-free a-minimum essential medium supplemented
with 0.5 g of 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetra-
zolium bromide and the purple formazan was extracted using
0.04 M HCl in 2-propanol. The extracted solution was mea-
sured at 570 nm using a UV=VIS spectrophotometer. To ob-
serve mineralization, ALP of cells was measured. ALP of
samples was extracted according to the ALP assay kit (Takala
Bio, Shiga, Japan) protocol and measured at 405 nm.
The other samples were prepared for western immu-
noblotting to compare adhesion signals between scaffolds.
Lysate proteins were separated via 8% sodium dodecyl
sulfate–polyacrylamide gel electrophoresis gel and transferred
to polyvinylidene fluoride (PVDF) membranes using an I-Blot
transfer machine (Invitrogen, Carlsbad, CA) for 6 min. The
membranes were reacted with primary antibodies for 12 h
at 48C. The antibodies used were anti-integrin a5 (H-104),
-c-Src (B-12), -phospho-Tyr925 focal adhesion kinase (FAK)
(Santa Cruz Biotech, Santa Cruz, CA), -phospho-Tyr118
paxillin, -phospho-Tyr416 c-Src, -phospho-ERK1=2, -ERK1=2
(Cell Signaling Technology, Beverly, MA), -FAK, -paxillin
(BD Bioscience, San Jose, CA), and -phospho-Tyr397 FAK
(Chemicon, Temecula, CA). After reaction with the pri-
mary antibody, the membrane was incubated again with
secondary antibody (mouse or rabbit) for 1 h at room tem-
perature. The HRP activity was measured using an ECL kit
(Pierce, Rockford, IL). Detailed information of antibodies for
western blotting is given in Supplemental Material (available
online at www.liebertonline.com).
FIG. 1. Characteristics of various pore-sized fibrous silk fibroin scaffolds and sponge-type PLA scaffold. (A) Scanning electron
microscope photographs of scaffold cross-sections: (A-a) N-ESF, (A-b) S-ESF, (A-c) P-ESF (M-ESF), (A-d) L-ESF, and (A-e) PLA
purchased from BD Falcon. Also, magnified individual fiber of ESF is shown (A-f). (B) Average pore diameter. (C) Porosity. (D)
Water uptake. Data are shown as mean standard error of the mean (n¼ 4). N=A, not available; N-ESF, nonporous electrospun
silk fibroin; S-ESF, small ESF; M-ESF, medium ESF; P-ESF, ESF with pores; L-ESF, large ESF; PLA, polylactic acid.
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Animal surgery for in vivo test
To evaluate the performance in vivo, 24 male Sprague–
Dawley rats (300–350 g) were anesthetized via isoflurane–
oxygen inhalation (FORENE; Abbott AG, Neuhofstrasse,
Switzerland). After incision of skin and muscle, the exposed
calvaria were punched using a 7.00-mm-diameter drill, and
each scaffold was subsequently transplanted. Then the rats
were allowed to recover for 7 weeks and sacrificed with CO2
gas to retrieve the calvaria. The entire procedure followed the
policy of the Seoul National University Animal Care and
Ethics Committee.
Radiographic and histological evaluation
The rat calvaria specimens were fixed with 10% formalin
for 24 h. Then radiographs of the specimens were taken using
mCT (SKYSCAN 1072-32, Kontich, Belgium). A total of 359
slices were imaged (19.53125mm per slice for 3.4-s exposure)
for every specimen, and the pictures were analyzed and used
to generate a 3D image of 10241024 pixels using CT re-
construction software from SKYSCAN. The regenerated
bone area was quantified using an image analysis program
(Image Pro 6.2; Media Cybernetics, Bethesda, MD).
After radiographic testing, samples were decalcified in
a 10% ethylenediaminetetraacetic acid solution, which was
changed every day for 3 weeks. Then samples were em-
bedded with paraffin and cut into 6-mm sections. The tissue
slices were subjected to deparaffinization and hydration
steps and then stained with hematoxylin for 10 min and
eosin for 2 min. Histology photographs were taken under a
BX-51 microscope (OLYMPUS, Tokyo, Japan) and analyzed
(Image Pro 6.2).
FIG. 2. (A) Scanning electron microscope photographs of osteoblasts on each scaffold: (A-a) 1 day, (A-b) 7 days, and (A-c)
28 days on P-ESF; (A-d) 1 day, (A-e) 7 days, and (A-f) 28 days on PLA scaffold. Quantification of total DNA contents (B) and
MTT assay level (C) of cells in the scaffolds were measured at 1, 7, and 28 days after seeding 2.5105 osteoblasts. Alkaline
phosphatase activities of cells in the scaffolds were tested at 7, 14, and 21 days after seeding (D). Data are shown as
mean standard error of the mean (n¼ 5). *Statistically significant (Student’s t-test: *p< 0.05, **p< 0.01).
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Statistical analysis
The quantitative data were expressed as mean standard
error of the mean and analyzed using T-test (Student’s t-test)
analysis software (Origin8.0; Origin Lab, Northampton, MA).
The differences were considered statistically significant at
*p< 0.05 and **p< 0.01.
Results
Pore size-controllable ESF has favorable
characteristics as a bioactive scaffold
The internal structure of scaffolds was evaluated by SEM
(Fig. 1A). N-ESF (Fig. 1A-a), which was fabricated without
porogen NaCl particles, did not show any pores except very
tiny spaces around the SF fiber entanglements. However, we
could control the pores of ESFs with a salt-leaching method
using various sized porogens. The final pore sizes of ESFs
were controlled from 0 to 500mm depending on the added
porogen sizes (Fig. 1B). The small-sized (S-ESF; Fig. 1A-b),
medium-sized (M-ESF; Fig. 1A-c), and large-sized (L-ESF;
Fig. 1A-d) ESFs were prepared with 50–100, 100–200, and
300–500 mm sized NaCl during a fabrication process, re-
spectively. Every ESF was composed of SF fiber assemblies
of 200–500 nm in diameter. For biological comparison, a PLA
scaffold purchased from BD Falcon (pore size is 150–230 mm;
Fig. 1A-e) was used as a control and compared with M-ESF,
which has a similar pore size.
Besides pore size, porosity and water uptake of scaffolds,
both of which are important for cytocompatibility, were also
measured. Usually, scaffold porosity is defined in the range
of 80–90%. When the salt-leaching method is used for ob-
taining pore structure, the porosity is mainly determined by
the amount of porogen. Figure 1C exhibits the porosities of
ESFs prepared with 0.15 g=mL particles of different sized
NaCl. All samples demonstrated 90–93% porosity regardless
of porogen size except N-ESF. The porosity of N-ESF was
measured at about 70%, even though the porogen was not
added. This was attributed to the tremendous number of tiny
spaces created by the fibrous structure, and this porosity
value is similar to that of the 2D fibrous mat fabricated by a
common electrospinning process.17
Water uptake is closely related to the scaffold porosity
because water occupied the vacant space (pore) in the scaf-
fold when the ESF was immersed in the solution. As shown
in Figure 1D, the tendency of water uptake was very similar
to that of the porosity value. The amount of water adsorbed
by ESF with 90% porosity was approximately 1200% of its
own weight. Therefore, controllability of the pore structure,
porosity, and water uptake of new ESF could enable us to
tailor scaffolds suitable for specific cell types or tissues nee-
ded for regenerative medicine.
Pore size-controllable ESF for bone regeneration in vitro
The morphologies of cultured cells in the P-ESF (a–c) and
PLA (d–f ) scaffolds were evaluated by SEM at 1 day (a, d),
7 days (b, e), and 28 days (c, f ) after cell seeding (Fig. 2A). In
N-ESF, no cell was observed inside the scaffold because of
the absence of pores. However, many osteoblasts were ob-
served in the middle of both the P-ESF and PLA groups. A
greater number of cells were found in P-ESF than in PLA. At
28 days after seeding, osteoblasts inside P-ESF showed five
to six extending filopodia, indicating a large attached area to
the scaffold compared with cells on PLA.
Cellular proliferation and metabolic activities were mea-
sured by total DNA content (Fig. 2B) and MTT assays
(Fig. 2C), respectively. Initially, the number of cells on each
scaffold steadily increased with time regardless of scaffold
type. One day after seeding, PLA showed a significant de-
crease compared with other groups ( p< 0.05). One week
after seeding, the DNA content and MTT results of PLA
surpassed those of N-ESF. Interestingly, P-ESF showed a
significant increase of DNA content and MTT level com-
pared with the other scaffold types at any observed time
( p< 0.05). Differentiation on each scaffold was measured
using ALP activities (Fig. 2D). The ALP assay result was
similar to previous MTT and total DNA results. Initially, the
ALP level of the N-ESF group was higher than that of cells
on PLA, although the ALP level of PLA groups was higher
than the N-ESF group after 7 days. However, the P-ESF
group showed the highest ALP level continuously over the
culture period.
Additionally, immunoblotting was performed to evaluate
cellular adhesion with antibodies against adhesion-related
proteins (Fig. 3). It is obvious that the protein expressions of
integrin a5, FAK, its phosphorylated proteins (pY397FAK and
pY925FAK), and phosphorylated c-Src (pY416c-Src) are more
intense with P-ESF than other scaffold types at 1 day after
seeding.
FIG. 3. Western blot analysis with antibodies against
adhesion-related proteins, integrin a5, focal adhesion kinase
(FAK), c-Src, paxillin, ERK, and phosphorylated forms of
FAK, c-Src, paxillin, and ERK, at 1 day after seeding osteo-
blasts onto PLA, P-ESF, and N-ESF scaffolds. ERK was used
as an internal standard.
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Pore size-controllable ESF for bone formation in vivo
To investigate bone regeneration in vivo, the scaffolds
were implanted into punched (7 mm diameter) rat calvaria.
As negative and positive controls, no defect and only defect
(without any scaffolds) were performed, respectively. Sam-
ples were obtained at 7 weeks after the operation. Upon
macroscopic evaluation (Fig. 4), the defected bone did not
reveal any sign of repair; necrosis was observed in the defect-
only group. However, in groups treated with PLA and
N-ESF scaffolds, the defect zones were regenerated partly
with maintaining the original scaffold shapes. But notice-
ably, the bone defect of one-third of the rats with P-ESF
seemed to be mostly recovered with almost absorbed scaf-
folds at 7 weeks after implantation.
To confirm the regenerated bone area, defected rat cal-
varia were scanned by mCT (Fig. 4A). The newly generated
bone volume was calculated quantitatively using 3D images
(Fig. 4B). As expected, the bone volume of the ESF-treated
group was good, regardless of the presence of pores, com-
pared with the PLA-treated group. In particular, the P-ESF
group yielded higher bone volumes of 78.30% than the
N-ESF (54.72%) and PLA (49.31%) groups, compared with
the no defect group (100%).
The histological evidence of the effect of tissue compati-
bility and bone regeneration for each scaffold are shown in
Figure 5A–E. The vacancies depicted in the figure were
caused by xylene treatment during the staining. According to
H&E staining, there was no sign of abnormal tissue response
for all scaffold types. Newly regenerated bone cells (deep
pink) were observed with inflammation cells in the P-ESF
group. Figure 5F denotes the magnified image of cells within
the P-ESF group.
Discussion
The native ECM is a complex fibrous matrix with struc-
tural and regulatory proteins. Electrospun porous scaffolds
could function like ECM and provide a favorable condition
for normal cellular function. In particular, 3D electrospun
scaffolds closely mimic native ECM because of the presence
of many fine fibers with a small diameter less than several
hundred nanometers.13,14 Until now, there has been no re-
port of 3D electrospun scaffolds with interconnective mac-
ropores.
In this study, macropores among ESF were easily con-
trolled using a salt-leaching method by changing NaCl par-
ticle size. The porosity of the newly developed ESF exceeded
FIG. 4. Bone formation mea-
sured with reconstructed three-
dimensional microcomputed
tomography images of rat’s cal-
varia taken at 7 weeks after
critical bone defects and implan-
tation of scaffolds (A): (A-a) no
defect, (A-b) only defect, (A-c)
defect and N-ESF implanted,
(A-d) defect and P-ESF im-
planted, and (A-e) defect and
PLA implanted. The dotted circle
indicates the original defect. (B)
Quantification of the regenerated
bone area of the microcomputed
tomography images. Data are
shown as mean SD (n¼ 2, no
defect; n¼ 5, only defect and
N-ESF; n¼ 6, P-ESF and PLA).
*Statistically significant (Stu-
dent’s t-test: *p< 0.05).
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90% and it was not significantly changed above 0.10 g=mL
when the amount of added NaCl particles exceeded 0.05 g
per unit of ESF dispersion (mL). However, when over
0.20 g=mL of NaCl particles was added, the ESF structure
was hardly maintained in the process. Consequently, the
optimum amount of NaCl particles seems to be 0.10–
0.15 g=mL (data not shown). For N-ESF, the porosity value of
70% was attributed to the tremendous number of tiny spaces
created by nanofibrous structure, and this porosity value is
similar to that of 2D nanofibrous mat fabricated by a common
electrospinning process.17 Because pore size and porosity of
scaffolds have an effect on the mechanical properties, which
are important for bone regeneration,21 we tested those in dry
and water uptake condition (detailed results and discussion
are given in Supplemental Material).
We studied ESF with osteoblasts (MC3T3-E1) because silk
fibroin is one of several well-known biomaterials for bone
regeneration.8,9 The osteoblasts were observed in the center
of 3D scaffolds such as P-ESF and PLA, even at 4 days after
seeding (Fig. 2), which means cells could easily migrate into
the scaffolds with suitable pores or porosity. This result was
supported by MTT assay and the DNA contents of P-ESF
and PLA groups. However, P-ESF showed a higher cellular
viability and proliferation compared with PLA, indicating
a higher migration of cells along the electrospun fibers in
P-ESF. Additionally, the ECM-like electrospun 3D structure
of P-ESF may provide a favorable condition for cellular
adhesion because many extending filopodia of osteoblasts
were observed, which is consistent with a previous report.22
Also, we observed greater protein expression of activated
adhesion-related proteins, including FAK,23,24 in the P-ESF
than in PLA using western blot analyses. In this study,
P-ESF steadily provided a favorable condition for cell
adhesion, migration, and proliferation similar to natural
ECM for osteoblasts.
ALP is commonly used as a bone formation marker in-
volved in bone mineral production.25,26 The ALP assay result
over time was found to be similar to the cell proliferation
data. Higher cell density in P-ESF group resulting from the
higher cell viability and proliferation during early periods of
culture may lead to elevated ALP levels, indicating an en-
hanced differentiation of osteoblasts.27–29
To assess the bone regeneration ability and compatibility
in the defect area, we performed critical bone defects in vivo.
The scaffolds were implanted into punched rat calvaria and
then recovered at 7 weeks after the operation. According to
mCT data (Fig. 4), bone is depicted as white and the defect
area is black. There is vacant area present in a normal cal-
varium because the X-ray beam intensity was set high en-
ough to examine the bone regeneration more specifically.
In our study, bone regeneration occurred significantly in the
N-ESF and P-ESF groups compared with PLA scaffold-
treated groups. In the N-ESF group, the newly formed bone
filled the edge of the defect, but the recovered area was in-
sufficient. In case of P-ESF, it was difficult to observe the
circular shape of the defect and a significant area was filled
FIG. 5. Histological evaluation of bone formation at 7 weeks after bone defects with hematoxylin and eosin staining. (A) No
defect, (B) only defect, (C) defect and N-ESF implanted, (D) defect and P-ESF implanted, and (E) defect and PLA implanted.
(F) New bone formation in the P-ESP scaffold. Arrow indicates new bone formation. Color images available online at
www.liebertonline.com=ten.
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with new bone. Moreover, bone volume recovery (78.30%) in
the P-ESF group is comparable to that of N-ESF (54.72%) and
PLA (49.31%). Regarding N-ESF, the lower bone volume
observed compared with P-ESF is due to a lack of porous
structure. ESF seems to be a superior biomaterial to PLA
with pores because ESF with or without pores showed a
higher recovery than PLA with pores. This result suggests
that the fibrous structure with macropores is very effective
for conducting bone regeneration in vivo. The histological
evidence of tissue compatibility and scaffold degradation is
shown in Figure 5. In H&E staining, there was no sign of
severe pathologic tissue response for all scaffold types. This
may be due to the excellent biocompatibility of ESF and PLA
as previously reported.30–33 New bone formation was the
most prominent occurrence in the P-ESF group. In Figure 5F,
a piece of the regenerated bone was stained pink with the
surrounding inflammation cells. Neovascularization, which
involves formation of microvascular networks induced by
inflammatory response after scaffold implantation, is as-
sumed to be crucial for successful engraftment.34 Moreover,
the resorption of biomaterial begins in the presence of in-
flammatory cells.35 Our results that the regenerated bone
surrounded by inflammatory cells indicate that silk fibroin is
a suitable biomaterial from the perspective of biodegrad-
ability and tissue healing.
In conclusion, we fabricated an ESF with macropores that
can be altered using salt-leaching method. The diameter of
electrospun silk fiber was 200–400 nm, providing an ECM-
like structure that has high porosity and excellent water
uptake. P-ESF showed higher bone formation activities com-
pared with a pore size-matched sponge-type PLA scaffold
in vitro and in vivo. A mean of 78.30% of normal bone area
was attained in the P-ESF implantation group at 7 weeks
after creating a critical bone defect in rat calvaria. The
sponge-type PLA implantation group showed only a 49.31%
bone regrowth area. Therefore, P-ESF may be a good bone
substitute for large bone defects because of its ECM-like
structure, biocompatibility, and osteoconductivity.
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